Cargando…

Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study

BACKGROUND: Recent studies on renin-angiotensin system (RAS) inhibitors have reported a reduced risk of Alzheimer’s disease (AD). Nevertheless, the effect of RAS inhibitor type and blood–brain barrier (BBB) permeability on the risk of AD is still unknown. OBJECTIVES: To assess the effects of RAS inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyun Woo, Kim, Seungyeon, Jo, Youngkwon, Kim, Youjin, Ye, Byoung Seok, Yu, Yun Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025478/ https://www.ncbi.nlm.nih.gov/pubmed/36949774 http://dx.doi.org/10.3389/fnagi.2023.1137197

Ejemplares similares

Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
por: Jo, Youngkwon, et al.
Publicado: (2022)

Association between migraine and Alzheimer’s disease: a nationwide cohort study
por: Kim, Jaeho, et al.
Publicado: (2023)

Role of angiotensin II in aging
por: Yi, Wenmin, et al.
Publicado: (2022)

Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19
por: Bueno, Valquiria, et al.
Publicado: (2023)

Chronic pain is a risk factor for incident Alzheimer’s disease: a nationwide propensity-matched cohort using administrative data
por: Bornier, Nadège, et al.
Publicado: (2023)

Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers
por: Choi, Won Joon, et al.
Publicado: (2022)

Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea
por: Jung, Mi‐Hyang, et al.
Publicado: (2021)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Angiotensin (1–7) Expressing Probiotic as a Potential Treatment for Dementia
por: Hernandez, Abbi R., et al.
Publicado: (2021)

Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
por: Hu, Wei-Syun, et al.
Publicado: (2023)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021)

Exploiting the neuroprotective effects of α-klotho to tackle ageing- and neurodegeneration-related cognitive dysfunction
por: Hanson, Kelsey, et al.
Publicado: (2021)

Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study
por: Chang, Chia-Hsuin, et al.
Publicado: (2014)

Incidence of Parkinson’s disease and modifiable risk factors in Korean population: A longitudinal follow-up study of a nationwide cohort
por: Kang, Sung Hoon, et al.
Publicado: (2023)

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
por: Kim, Eun Seok, et al.
Publicado: (2013)

Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series
por: Lee, Su Jin, et al.
Publicado: (2021)

Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
por: Kim, Da-Rae, et al.
Publicado: (2013)

Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians
por: Park, Ji Young, et al.
Publicado: (2016)

Impact of transcranial direct current stimulation on white matter microstructure integrity in mild cognitive impairment patients according to effect modifiers as risk factors for Alzheimer’s disease
por: Kang, Dong Woo, et al.
Publicado: (2023)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

Angiotensin II receptor blockers induce autophagy in prostate cancer cells
por: Woo, Yunseo, et al.
Publicado: (2017)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?
por: Jang, Byoung Kuk
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Sex differences in the structural rich-club connectivity in patients with Alzheimer’s disease
por: Kim, Soo-Jong, et al.
Publicado: (2023)

The potential neuroprotective effects of stingless bee honey
por: Zulkifli, Nurdarina Ausi, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model
por: Choi, Jong-Il, et al.
Publicado: (2016)

Modulation of associations between education years and cortical volume in Alzheimer’s disease vulnerable brain regions by Aβ deposition and APOE ε4 carrier status in cognitively normal older adults
por: Kim, Hak-Bin, et al.
Publicado: (2023)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
por: Al-Hussaniy, Hany A., et al.
Publicado: (2023)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Editorial: Infection, inflammation, and neurodegeneration: A critical path to Alzheimer's disease, Volume II
por: Mancuso, Roberta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_44gri250mj3rkgqmuuv4epl23t